Indication: Liver cancer

Source: American Academy of Cancer Research Meeting, October 2002.

Research: A five-year clinical study conducted in Japan examined liver cancer prevention in high risk liver cancer patients (hepatitis C virus carriers, those with cirrhosis and/or those having a family history).

Results: The study showed 50% hepatocellular carcinoma (liver cancer) suppression in those participants who consumed daily, a combination of natural tomato extract (Lyc-O-Mato®) providing 10 mg carotenes, (30% alpha, 60% beta-carotene) and 50 mg alpha tocopherols (vitamin E) as well as toco­trienols. These significantly positive results suggest treating patients at high risk for cancer with a mixture of natural tomato extract, carotenes and vitamin E holds promise as a viable clinical application.